Itraconazole lung concentrations in haematological patients

被引:0
|
作者
Coronel, B
Levron, JC
Dorez, D
Van Devenne, A
Archimbaud, E
Mercatello, A
机构
[1] Hop Edouard Herriot, Intens Care Unit, Lyon, France
[2] Direct Rech, Janssen Res Fdn, Val De Reuil, France
[3] Hautepierre Hosp, Strasbourg, France
[4] Hop Edouard Herriot, Dept Hematol, Lyon, France
关键词
itraconazole; antimycotic chemotherapy; pharmacokinetics; lung concentration;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Itraconazole distribution is largely dependent on its high liposolubility. Intrapulmonary lung concentrations remain unknown in haematological patients. We report itraconazole lung concentrations in such patients treated with itraconazole. Itraconazole and hydroxy-itraconazole were measured by high-performance liquid chromatography in concomitant blood samples and lung post-mortem biopsies (three cases) or lung lobectomy (one case). These itraconazole and metabolite lung concentrations were sufficient to be active on Aspergillus.
引用
收藏
页码:125 / 127
页数:3
相关论文
共 50 条
  • [21] ITRACONAZOLE CONCENTRATIONS IN AIRWAY FLUID AND TISSUE
    WATKINS, DN
    BADCOCK, NR
    THOMPSON, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (02) : 206 - 207
  • [22] Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients
    Matsuda, Yuya
    Nakagawa, Shunsaku
    Yano, Ikuko
    Masuda, Satohiro
    Imai, Satoshi
    Yonezawa, Atsushi
    Yamamoto, Takashi
    Sugimoto, Mitsuhiro
    Tsuda, Masahiro
    Tsuzuki, Tetsunori
    Omura, Tomohiro
    Nakagawa, Takayuki
    Chen-Yoshikawa, Toyofumi Fengshi
    Nagao, Miki
    Date, Hiroshi
    Matsubara, Kazuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (04) : 397 - 402
  • [23] Plasma itraconazole concentrations in patients with neutropenia: Advantages of a divided daily dosage regimen
    Poirier, JM
    Hardy, S
    Isnard, F
    Tilleul, P
    Weissenburger, J
    Cheymol, G
    THERAPEUTIC DRUG MONITORING, 1997, 19 (05) : 525 - 529
  • [24] Immunomodulatory activity of itraconazole in lung
    Naranjo, Tonny W.
    Lopera, Damaris
    Felipe Zuluaga, Andres
    Elena Cano, Luz
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (12) : 2603 - 2609
  • [25] New Formulation Suba-Itraconazole Prophylaxis in Patients with Haematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation
    Lindsay, Julian
    Sandaradura, Indy
    Wong, Kelly
    Arthur, Christopher
    Stevenson, William
    Kerridge, Ian
    Fay, Keith
    Coyle, Luke
    Greenwood, Matthew
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S284 - S285
  • [26] Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy
    Schuler, Ulrich
    Bammer, Susanne
    Aulitzky, Walter E.
    Binder, Claudia
    Boehme, Angelika
    Egerer, Gerlinde
    Sandherr, Michael
    Schwerdtfeger, Rainer
    Silling, Gerda
    Wandt, Hannes
    Glasmacher, Axel
    Ehninger, Gerhard
    ONKOLOGIE, 2007, 30 (04): : 185 - 191
  • [27] Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations
    Kallee, Simon
    Scharf, Christina
    Schroeder, Ines
    Paal, Michael
    Vogeser, Michael
    Irlbeck, Michael
    Zander, Johannes
    Zoller, Michael
    Jung, Jette
    Kneidinger, Nikolaus
    Schneider, Christian
    Michel, Sebastian
    Liebchen, Uwe
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [28] Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units
    Vandewoude, K
    Vogelaers, D
    Decruyenaere, J
    Jaqmin, P
    DeBeule, K
    VanPeer, A
    Woestenborghs, R
    Groen, K
    Colardyn, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2714 - 2718
  • [30] Plasma methylprednisolone concentrations are considerably increased by itraconazole
    Varis, T
    Kaukonen, KM
    Kivistö, KT
    Neuvonen, PJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R456 - R456